Disciplined Growth Investors Inc. MN Sells 3,802 Shares of Core Laboratories (CLB)

Disciplined Growth Investors Inc. MN cut its holdings in shares of Core Laboratories (NYSE:CLB) by 1.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 330,729 shares of the oil and gas company’s stock after selling 3,802 shares during the period. Disciplined Growth Investors Inc. MN owned about 0.75% of Core Laboratories worth $41,741,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of CLB. Wells Fargo & Company MN increased its stake in Core Laboratories by 7.1% during the first quarter. Wells Fargo & Company MN now owns 643,596 shares of the oil and gas company’s stock worth $69,651,000 after purchasing an additional 42,479 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Core Laboratories by 23.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,956 shares of the oil and gas company’s stock worth $320,000 after purchasing an additional 557 shares during the period. Prudential Financial Inc. increased its stake in Core Laboratories by 183.9% during the first quarter. Prudential Financial Inc. now owns 75,439 shares of the oil and gas company’s stock worth $8,164,000 after purchasing an additional 48,870 shares during the period. Swiss National Bank increased its stake in Core Laboratories by 2.3% during the first quarter. Swiss National Bank now owns 76,900 shares of the oil and gas company’s stock worth $8,322,000 after purchasing an additional 1,700 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its stake in Core Laboratories by 1.6% during the first quarter. Schwab Charles Investment Management Inc. now owns 167,008 shares of the oil and gas company’s stock worth $18,074,000 after purchasing an additional 2,660 shares during the period.

CLB has been the topic of a number of recent research reports. ValuEngine upgraded shares of Core Laboratories from a “hold” rating to a “buy” rating in a research note on Tuesday, September 4th. Piper Jaffray Companies restated a “hold” rating and set a $96.00 target price on shares of Core Laboratories in a research note on Friday, July 27th. Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and set a $117.00 target price on the stock in a research note on Monday, August 13th. ABN Amro lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, July 2nd. Finally, Zacks Investment Research lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, July 4th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $115.00.

CLB stock opened at $108.91 on Monday. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.85 and a current ratio of 2.24. Core Laboratories has a fifty-two week low of $87.66 and a fifty-two week high of $130.34. The company has a market cap of $4.90 billion, a P/E ratio of 49.88, a PEG ratio of 3.79 and a beta of 1.50.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, July 25th. The oil and gas company reported $0.59 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.59. Core Laboratories had a net margin of 13.32% and a return on equity of 64.13%. The firm had revenue of $175.48 million for the quarter, compared to analyst estimates of $174.47 million. During the same period in the prior year, the firm earned $0.51 earnings per share. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. analysts anticipate that Core Laboratories will post 2.44 EPS for the current year.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.

See Also: Moving Average – How it Helps Investors in Stock Selection

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply